Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer.
Breast cancer
MenaINV
NF-κB
Notch1
TMEM doorways
Journal
Breast cancer research : BCR
ISSN: 1465-542X
Titre abrégé: Breast Cancer Res
Pays: England
ID NLM: 100927353
Informations de publication
Date de publication:
06 04 2023
06 04 2023
Historique:
received:
24
10
2022
accepted:
27
02
2023
medline:
10
4
2023
entrez:
6
4
2023
pubmed:
7
4
2023
Statut:
epublish
Résumé
Metastasis is a multistep process that leads to the formation of clinically detectable tumor foci at distant organs and frequently to patient demise. Only a subpopulation of breast cancer cells within the primary tumor can disseminate systemically and cause metastasis. To disseminate, cancer cells must express MenaINV, an isoform of the actin regulatory protein Mena, encoded by the ENAH gene, that endows tumor cells with transendothelial migration activity, allowing them to enter and exit the blood circulation. We have previously demonstrated that MenaINV mRNA and protein expression is induced in cancer cells by macrophage contact. In this study, we discovered the precise mechanism by which macrophages induce MenaINV expression in tumor cells. We examined the promoter of the human and mouse ENAH gene and discovered a conserved NF-κB transcription factor binding site. Using live imaging of an NF-κB activity reporter and staining of fixed tissues from mouse and human breast cancer, we further determined that for maximal induction of MenaINV in cancer cells, NF-κB needs to cooperate with the Notch1 signaling pathway. Mechanistically, Notch1 signaling does not directly increase MenaINV expression, but it enhances and sustains NF-κB signaling through retention of p65, an NF-κB transcription factor, in the nucleus of tumor cells, leading to increased MenaINV expression. In mice, these signals are augmented following chemotherapy treatment and abrogated upon macrophage depletion. Targeting Notch1 signaling in vivo decreased NF-κB signaling activation and MenaINV expression in the primary tumor and decreased metastasis. Altogether, these data uncover mechanistic targets for blocking MenaINV induction that should be explored clinically to decrease cancer cell dissemination and improve survival of patients with metastatic disease.
Identifiants
pubmed: 37024946
doi: 10.1186/s13058-023-01628-1
pii: 10.1186/s13058-023-01628-1
pmc: PMC10080980
doi:
Substances chimiques
NF-kappa B
0
Receptor, Notch1
0
NOTCH1 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Subventions
Organisme : NIH HHS
ID : S10 OD019961
Pays : United States
Organisme : NIGMS NIH HHS
ID : K12 GM102779
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA237851
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA243350
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240646
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255153
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2022 Feb 2;13(1):626
pubmed: 35110548
Toxicol Sci. 2004 Nov;82(1):341-58
pubmed: 15319485
Cell Death Discov. 2018 Sep 21;4:37
pubmed: 30275982
J Clin Invest. 2011 Feb;121(2):508-9
pubmed: 21266769
Cancer Res. 2009 Dec 15;69(24):9498-506
pubmed: 19934330
Biomedicines. 2017 Aug 22;5(3):
pubmed: 28829404
Nat Rev Drug Discov. 2003 Aug;2(8):611-2
pubmed: 12908468
Cancer Cell. 2008 Sep 9;14(3):263-73
pubmed: 18772115
Cell. 2004 Aug 6;118(3):285-96
pubmed: 15294155
Oncotarget. 2016 May 31;7(22):33004-15
pubmed: 27105509
J Cell Biol. 2006 May 8;173(3):395-404
pubmed: 16651380
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7159-E7168
pubmed: 28784776
Cancer Res. 1999 Jul 15;59(14):3299-303
pubmed: 10416581
Nat Struct Mol Biol. 2008 Dec;15(12):1263-71
pubmed: 19011635
Cancer Res. 2014 Sep 15;74(18):5057-69
pubmed: 25082815
Sci Transl Med. 2017 Jul 5;9(397):
pubmed: 28679654
Cell Mol Life Sci. 2009 May;66(10):1631-46
pubmed: 19165418
Nature. 2003 Feb 6;421(6923):639-43
pubmed: 12571598
J Clin Invest. 2008 Jan;118(1):217-28
pubmed: 18079963
Cancer Res. 2015 Sep 1;75(17):3479-91
pubmed: 26269531
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cancer Res. 2015 Jun 15;75(12):2405-10
pubmed: 25998620
Nat Rev Cancer. 2019 Dec;19(12):667-685
pubmed: 31645711
J Clin Med. 2021 May 27;10(11):
pubmed: 34071839
Nature. 2009 Nov 12;462(7270):182-8
pubmed: 19907488
Intravital. 2013 Apr 1;2(2):e25294
pubmed: 25013744
Clin Exp Metastasis. 2011 Aug;28(6):515-27
pubmed: 21484349
J Cell Sci. 2011 Jul 1;124(Pt 13):2120-31
pubmed: 21670198
J Biol Chem. 2014 May 2;289(18):12457-66
pubmed: 24634219
Sci Rep. 2016 Nov 30;6:37874
pubmed: 27901093
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
EMBO J. 2006 Jan 11;25(1):129-38
pubmed: 16319921
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17406-11
pubmed: 16293698
Cancer Cell. 2014 May 12;25(5):605-20
pubmed: 24823638
Science. 2009 Apr 10;324(5924):242-6
pubmed: 19359585
Nat Commun. 2021 Dec 15;12(1):7300
pubmed: 34911937
Cell. 2005 Jul 1;121(7):977-90
pubmed: 15989949
Cancer Res. 2019 Sep 15;79(18):4567-4576
pubmed: 31431464
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Mol Med Rep. 2020 Sep;22(3):1803-1810
pubmed: 32582987
Breast Cancer Res. 2010;12(6):R101
pubmed: 21108830
PLoS One. 2009 Sep 29;4(9):e7163
pubmed: 19787057
Clin Cancer Res. 2008 Aug 1;14(15):4943-50
pubmed: 18676769
Oncogene. 2006 Oct 30;25(51):6887-99
pubmed: 17072334
Oncogene. 2014 Mar 13;33(11):1341-7
pubmed: 23524584
Cell. 2021 Apr 29;184(9):2471-2486.e20
pubmed: 33878291
Oncogene. 1998 Oct 8;17(14):1821-6
pubmed: 9778048
J Biol Chem. 1999 Nov 5;274(45):32091-8
pubmed: 10542243
Biochim Biophys Acta. 2006 Jan-Feb;1759(1-2):99-107
pubmed: 16494957
Cancers (Basel). 2022 Jan 27;14(3):
pubmed: 35158902
J Exp Med. 1996 May 1;183(5):2025-32
pubmed: 8642313
Lab Invest. 2008 Jan;88(1):11-7
pubmed: 18059366
Am J Pathol. 2003 Nov;163(5):2113-26
pubmed: 14578209
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
Cell. 1996 Oct 18;87(2):227-39
pubmed: 8861907
PLoS Genet. 2011 Aug;7(8):e1002218
pubmed: 21876675
Mol Cancer Res. 2012 Nov;10(11):1403-18
pubmed: 23024188
Immunol Rev. 2012 Mar;246(1):379-400
pubmed: 22435567
Breast Cancer Res. 2018 Apr 10;20(1):24
pubmed: 29636067
Sci Signal. 2014 Nov 25;7(353):ra112
pubmed: 25429076
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Anticancer Res. 2013 Mar;33(3):801-8
pubmed: 23482747
Cancer Res. 2004 Oct 1;64(19):7022-9
pubmed: 15466195
Breast Cancer Res. 2012 Oct 31;14(5):R139
pubmed: 23113900
Oncogene. 2017 May 11;36(19):2680-2692
pubmed: 27893712
Science. 2004 Oct 22;306(5696):704-8
pubmed: 15499023
Trends Cell Biol. 2017 Aug;27(8):595-607
pubmed: 28412099